Detection and quantification of residual disease in chronic myelogenous leukemia
- 1 June 2000
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 14 (6) , 998-1005
- https://doi.org/10.1038/sj.leu.2401811
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 85 references indexed in Scilit:
- Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCRLeukemia, 1999
- Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a ‘real time’ quantitative RT-PCR assayLeukemia, 1999
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real‐time quantitative RT‐PCRBritish Journal of Haematology, 1998
- Which compartments are involved in Philadelphia‐chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May‐Grünwald‐Giemsa staining and fluorescence in situ hybridization techniquesBritish Journal of Haematology, 1997
- Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia: a metaphase‐FISH studyBritish Journal of Haematology, 1996
- Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-α (IFN-α) therapyCancer Genetics and Cytogenetics, 1995
- Improved results with PCR for chronic myeloid leukaemiaThe Lancet, 1990
- Characteristics of accelerated disease in chronic myelogenous leukemiaCancer, 1988
- Evidence of a New Chimericbcr/c-ablmRNA in Patients with Chronic Myelocytic Leukemia and the Philadelphia ChromosomeNew England Journal of Medicine, 1985